Acorda Therapeutics
ACOR
$0.52
Share price
-7.13%
Change (1 day)
-89.39%
Change (1 year)
Categories
Market capitalization of Acorda Therapeutics (ACOR)
Market cap: $0.01 Billion
As of June 2022 Acorda Therapeutics has a market cap of $0.01 Billion. This makes Acorda Therapeutics the world's 6234th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Acorda Therapeutics from 2006 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.01 B | -42.42% |
| 2021 | $0.02 B | -31.78% |
| 2020 | $0.03 B | -59.67% |
| 2019 | $0.09 B | -86.83% |
| 2018 | $0.73 B | -26.32% |
| 2017 | $1.00 B | 15.66% |
| 2016 | $0.86 B | -52.86% |
| 2015 | $1.83 B | 7.46% |
| 2014 | $1.71 B | 43.35% |
| 2013 | $1.19 B | 20.68% |
| 2012 | $0.98 B | 4.61% |
| 2011 | $0.94 B | -10.51% |
| 2010 | $1.05 B | 10.55% |
| 2009 | $0.95 B | 23.58% |
| 2008 | $0.77 B | 23.27% |
| 2007 | $0.62 B | 67.45% |
| 2006 | $0.37 B |
End of Day market cap according to different sources
On Jun 23rd, 2022 the market cap of Acorda Therapeutics was reported to be:
$0.01 Billion
$0.01 Billion
$6.31 Million
$5.32 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $6.58 B | 51,667.17% | 🇺🇸 USA |
 Repligen
RGEN | $9.19 B | 72,222.28% | 🇺🇸 USA |
 Affimed
AFMD | $0.40 B | 3,082.68% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $16.06 B | 126,268.23% | 🇺🇸 USA |